Rudolf F, Haraldsdottir T L, Mendes M S, Wagner A-J, Gomes V F, Aaby P, Østergaard L, Eugen-Olsen J, Wejse C
Bandim Health Project, International Network for the Demographic Evaluation of Populations and Their Health in Developing Countries Network, Bissau, Guinea-Bissau; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Bandim Health Project, International Network for the Demographic Evaluation of Populations and Their Health in Developing Countries Network, Bissau, Guinea-Bissau.
Int J Tuberc Lung Dis. 2014 Mar;18(3):277-85. doi: 10.5588/ijtld.13.0517.
The Bandim Health Project study area in Bissau, Guinea-Bissau.
To assess the potential usefulness of predictors (elsewhere applied) and clinical scores (TBscore and TBscore II) based on signs and symptoms typical of tuberculosis (TB) in case finding.
Observational prospective cohort study of patients with signs and symptoms suggestive of pulmonary TB (PTB) from 2010 to 2012.
We included 1089 PTB suspects with a mean age of 34 years (95%CI 33-35); human immunodeficiency virus (HIV) prevalence was 15.1%. PTB was diagnosed in 107 suspects (76.4% sputum smear-positive, 25.2% HIV-infected). Cough > 2 weeks had the highest diagnostic ability (area under the receiver operating characteristic curve [AUC] 0.66, 95%CI 0.62-0.71), while TBscore < 3 best excluded PTB (negative likelihood ratio [LR-] 0.3) when HIV status was not known. TBscore II ≥ 3 had the highest diagnostic ability in HIV-infected PTB suspects (AUC 0.62, 95%CI 0.53-0.72), while the absence of self-reported weight loss best excluded PTB (LR- 0.2). Cough > 2 weeks as a trigger for smear microscopy missed 32.1% of smear-positive PTB cases.
Case finding could be improved by screening symptomatic adults for cough and/or weight loss using TBscore II as the trigger for smear microscopy. To suspect PTB only in patients with cough > 2 weeks (non-HIV-infected) or with current cough, fever, weight loss or night sweats (HIV-infected) was not effective in patients whose HIV status was unknown at first visit.
几内亚比绍比绍的班迪姆健康项目研究区域。
评估基于结核病(TB)典型体征和症状的预测指标(在其他地方应用过)及临床评分(TBscore和TBscore II)在病例发现中的潜在有用性。
对2010年至2012年有疑似肺结核(PTB)体征和症状的患者进行观察性前瞻性队列研究。
我们纳入了1089例PTB疑似患者,平均年龄34岁(95%可信区间33 - 35);人类免疫缺陷病毒(HIV)感染率为15.1%。107例疑似患者被诊断为PTB(76.4%痰涂片阳性,25.2%感染HIV)。咳嗽超过2周具有最高的诊断能力(受试者工作特征曲线下面积[AUC]为0.66,95%可信区间0.62 - 0.71),而当HIV状态未知时,TBscore < 3最能排除PTB(阴性似然比[LR -]为0.3)。TBscore II≥3在感染HIV的PTB疑似患者中具有最高的诊断能力(AUC为0.62,95%可信区间0.53 - 0.72),而自述无体重减轻最能排除PTB(LR -为0.2)。以咳嗽超过2周作为涂片镜检的触发因素漏诊了32.1%的涂片阳性PTB病例。
通过使用TBscore II作为涂片镜检的触发因素,对有症状的成年人筛查咳嗽和/或体重减轻情况,可改善病例发现。对于首次就诊时HIV状态未知的患者,仅对咳嗽超过2周(未感染HIV)或有当前咳嗽、发热、体重减轻或盗汗(感染HIV)的患者怀疑为PTB并不有效。